Kaituo Pharmaceutical - B (09939.HK) announced its interim performance for the six months ending in June. The loss narrowed from RMB 0.212 billion in the same period last year to RMB 71.49 million, with a loss per share of 17 cents. No interim dividend was distributed. No revenue was recorded during the period.
《業績》開拓藥業(09939.HK)中期虧損收窄至7,149萬人民幣
The revenue of Concord Medical (09939.HK) narrowed to 71.49 million RMB in the first half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated